1014 Anti-Cd47 Immunotherapy Is Mediated by Cytotoxic NK Cells and Can Be Potentiated by IFN-α in the Murine Model of Cutaneous Lymphoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.1090
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded With Apoptotic Cells From Follicular Lymphoma Patients

Journal of Immunology
AllergyImmunology
2016English

Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2015English

Anticancer Effects of Anti-Cd47 Immunotherapy in Vivo

OncoImmunology
OncologyAllergyImmunology
2018English

Activated, but Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells

Journal of Immunology
AllergyImmunology
2003English

Rickettsial Infection in Murine Models Activates an Early Anti-Rickettsial Effect Mediated by NK Cells and Associated With Production of Gamma Interferon.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2001English

MyD88-Dependent IFN- Production by NK Cells Is Key for Control of Legionella Pneumophila Infection

Journal of Immunology
AllergyImmunology
2006English

Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN- Production by NK-T Cells

Journal of Immunology
AllergyImmunology
2000English

Transmissible Cytotoxicity of Multiple Myeloma Cells by Cord Blood-Derived NK Cells Is Mediated by Vesicle Trafficking

Cell Death and Differentiation
Cell BiologyMolecular Biology
2014English

Reversal of Tumor Acidosis by Systemic Buffering Reactivates NK Cells to Express IFN-γ and Induces NK Cell-Dependent Lymphoma Control Without Other Immunotherapies

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy